A Look at the Clinical Trial Data on a Treatment for Painful Diabetic Peripheral Neuropathy of the Feet

Guest: David M. Simpson, MD <br> <p><strong>Find the full <span style="text-decoration: underline;"><a href="https://www.qutenza.com/pdfs/Qutenza_Prescribing_Information.pdf">Prescribing Information here</a></span>.</strong></p> <p>Here to walk us through the clinical trial data that led to the FDA approval of a treatment option for painful diabetic peripheral neuropathy of the feet is Dr. David M. Simpson, a Professor of Neurology at the Icahn School of Medicine and Director of the Clinical Neurophysiology Laboratories and Neuromuscular Division at Mount Sinai in New York.</p> <p>QUTENZA^® is a registered trademark of Averitas Pharma, Inc.© <br />2021 Averitas Pharma, Inc. All rights reserved.<br />M-QZA-US-05-21-0006 May 2021</p>